Moderna and Aldevron recently expanded their partnership to support Moderna’s mRNA COVID-19 vaccine and clinical development therapeutic pipeline.
Aldevron is a provider of plasmid DNA,...
Although COVID-19 treatments azithromycin and hydroxychloroquine were often used in patients early in the pandemic, use decreased significantly by the end of 2020. But for drugs such as remdesivir and...
AstraZeneca’s COVID-19 vaccine, Vaxzevria, was recently granted emergency use in Japan for active immunization of individuals 18 years of age and older.
The Japanese Ministry of Health,...
Biogen and Capsigen recently entered into a collaboration to engineer novel adeno-associated virus (AAV) capsids to deliver gene therapies that address genetic causes of various central nervous system...
Pfizer and BioNTech recently announced the initiation of a Biologics License Application for full FDA approval of their mRNA COVID-19 vaccine
With the application, the companies submitted data t from...
CVS Health recently announced that it began administering COVID-19 vaccines at workplace vaccination sites to increase access to vaccinations.
The vaccination increase comes on the heels of...
Gavi, the Vaccine Alliance, recently announced that it signed an advance purchase agreement with Moderna for 500 million doses of its mRNA COVID-19 vaccine.
The initial supply under the...
Biogen recently announced new data from its portfolio of multiple sclerosis (MS) therapies.
The updates include data on quality of life benefits and findings from analyses on extended interval dosing...
Eli Lilly and Company recently requested that FDA revoke the emergency use authorization for its COVID-19 antibody treatment.
The FDA’s authorization has allowed providers to use 700 milligrams...
Roche recently confirmed positive results from the Phase 3 trial assessing its COVID-19 antibody cocktail, which aims to reduce coronavirus infection among household contacts of individuals infected...
In an official letter to President Joe Biden, PhRMA and over 30 leaders in the biopharmaceutical warned that eliminating intellectual property (IP) protections in COVID-19 vaccine development could...
Moderna recently announced that it is making new capital investments to increase global manufacturing capacity of its COVID-19 vaccine, mRNA-1273.
The company will make investments to increase...
FDA recently issued three guidance documents for COVID-19 vaccine developers and other medical product creators covering to address the current and potential future emergence of variants of...
Thermo Fisher Scientific recently launched its Vanquish Online 2D-Liquid Chromatography (LC) system, which offers versatility for multidimensional liquid chromatography.
The system offers a robust...
Bristol Myers Squibb recently announced it donated $53 million to Kyoto University to support its cancer immunotherapy research.
The funds will be used to finance the construction of the main building...
Pfizer recently announced that it has invested $120 million in four clinical-stage companies that focus on biotechnology innovation, oncology, rare disease, and immunology treatments.
Through the...
The Food and Drug Administration has issued the second emergency use authorization (EUA) for a COVID-19 vaccine to Moderna, allowing for national distribution.
All available data show that the vaccine...
HHS recently announced the government’s partnerships with large chain pharmacies and networks to boost access to COVID-19 vaccines across the US.
The partnership program will cover nearly 60...
States must address variations in flu vaccination uptake to ensure successful COVID-19 vaccine distribution, a new Kaiser Family Foundation (KFF) report indicates.
KFF obtained data from the...
Thermo Fisher Scientific and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University recently entered into an agreement to drive innovation across the...
